BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23385080)

  • 1. Intravenous immunoglobulin reduces β amyloid and abnormal tau formation caused by herpes simplex virus type 1.
    Wozniak MA; Itzhaki RF
    J Neuroimmunol; 2013 Apr; 257(1-2):7-12. PubMed ID: 23385080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.
    Wozniak MA; Frost AL; Itzhaki RF
    Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1.
    Wozniak MA; Frost AL; Preston CM; Itzhaki RF
    PLoS One; 2011; 6(10):e25152. PubMed ID: 22003387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons.
    Powell-Doherty RD; Abbott ARN; Nelson LA; Bertke AS
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HSV1 activity of brown algal polysaccharides and possible relevance to the treatment of Alzheimer's disease.
    Wozniak M; Bell T; Dénes Á; Falshaw R; Itzhaki R
    Int J Biol Macromol; 2015 Mar; 74():530-40. PubMed ID: 25583021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation.
    Wozniak MA; Itzhaki RF; Shipley SJ; Dobson CB
    Neurosci Lett; 2007 Dec; 429(2-3):95-100. PubMed ID: 17980964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulins for Alzheimer's disease.
    Puli L; Tanila H; Relkin N
    Curr Alzheimer Res; 2014; 11(7):626-36. PubMed ID: 25115546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1.
    Wozniak MA; Frost AL; Itzhaki RF
    J Alzheimers Dis; 2009; 16(2):341-50. PubMed ID: 19221424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for Alzheimer's disease.
    Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELISA measurement of specific antibodies to phosphorylated tau in intravenous immunoglobulin products.
    Loeffler DA; Klaver AC; Coffey MP
    Int Immunopharmacol; 2015 Oct; 28(2):1108-12. PubMed ID: 26330100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells.
    Alvarez G; Aldudo J; Alonso M; Santana S; Valdivieso F
    J Neurosci Res; 2012 May; 90(5):1020-9. PubMed ID: 22252837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.
    Wozniak MA; Mee AP; Itzhaki RF
    J Pathol; 2009 Jan; 217(1):131-8. PubMed ID: 18973185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus.
    Itzhaki RF
    Front Aging Neurosci; 2014; 6():202. PubMed ID: 25157230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of anti-Abeta1-42 antibodies in intravenous immunoglobulin with indirect ELISA: the problem of nonspecific binding.
    Klaver AC; Patrias LM; Coffey MP; Finke JM; Loeffler DA
    J Neurosci Methods; 2010 Mar; 187(2):263-9. PubMed ID: 20097229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted.
    Itzhaki RF
    J Alzheimers Dis; 2016 Oct; 54(4):1273-1281. PubMed ID: 27497484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus type I induces the accumulation of intracellular β-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells.
    Santana S; Recuero M; Bullido MJ; Valdivieso F; Aldudo J
    Neurobiol Aging; 2012 Feb; 33(2):430.e19-33. PubMed ID: 21272962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's Gone Viral: Could Herpes Simplex Virus Type-1 Be Stealing Your Memories?
    Khokale R; Kang A; Buchanan-Peart KR; Nelson ML; Awolumate OJ; Cancarevic I
    Cureus; 2020 Nov; 12(11):e11726. PubMed ID: 33403161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration.
    Gescher K; Kühn J; Lorentzen E; Hafezi W; Derksen A; Deters A; Hensel A
    J Ethnopharmacol; 2011 Mar; 134(2):468-74. PubMed ID: 21211557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin products contain specific antibodies to recombinant human tau protein.
    Smith LM; Coffey MP; Klaver AC; Loeffler DA
    Int Immunopharmacol; 2013 Aug; 16(4):424-8. PubMed ID: 23669333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.